Related Experiment Video
Updated: Aug 11, 2026
10:37
Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
The antiphospholipid syndrome: the clot thickens
1Department of Medicine, University of Louisville, KY 40292.
The Journal of the Kentucky Medical Association
|January 1, 1992
Summary
Antiphospholipid Syndrome is an autoimmune disorder primarily affecting young individuals. Diagnosis involves detecting anticardiolipin antibodies or lupus anticoagulants, with treatment focused on symptom management.
Area of Science:
- Autoimmune Disorders
- Hematology
- Reproductive Immunology
Background:
- Antiphospholipid Syndrome (APS) is a significant autoimmune condition.
- It is characterized by recurrent thrombosis and pregnancy complications.
- Thrombocytopenia is also a common clinical manifestation.
Purpose of the Study:
- To summarize the key features of Antiphospholipid Syndrome.
- To outline diagnostic criteria for APS.
- To describe current therapeutic approaches.
Main Methods:
- Diagnostic criteria for APS include clinical and laboratory findings.
- Laboratory diagnosis relies on the detection of antiphospholipid antibodies.
- Specific tests include anticardiolipin (aCL) antibody assays and lupus anticoagulant (LA) testing.
Main Results:
- APS diagnosis is confirmed by the presence of aCL antibody or LA.
- Recurrent venous or arterial thrombosis is a hallmark of the syndrome.
- Recurrent fetal loss and thrombocytopenia are other primary features.
Conclusions:
- Antiphospholipid Syndrome requires careful diagnosis based on specific antibody detection.
- Management of APS is primarily symptomatic.
- Further research may explore targeted therapies for APS.
More Related Videos
04:37Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
08:50Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis
Published on: January 9, 2026
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
01:30Peripheral Artery Disease I: Introduction
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...